Analysis Points to Downward Trend in US Clinical Research Spending

Published on: 

August 18, 2015.

New analysis of the U.S. government's Open Payments database, published in the August issue of Life Science Compliance Update, shows that industry spending on U.S-based clinical research dropped by 32 percent in the first year-over-year comparison since Open Payments data started to be collected.

The analysis shows that drug and device manufacturers reported about $1.5 billion in research payments from August through December 2013. This figure fell to around $1 billion during the same five-month time frame in 2014. As a result, physicians, academic institutions and third-party research organizations received nearly $500 million less in research funding during the comparable period in 2014, according to the article.